Amelioration of Behavioral Impairments and Neuropathology by Antiepileptic Drug Topiramate in a Transgenic Alzheimer’s Disease Model Mice, APP/PS1

by Brice Ayissi Owona, Caroline Zug, Hermann J. Schluesener, Zhi-Yuan Zhang
Published 2019-06-01

Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling

by Lei Li, Xiang-Hui Wu, Xiao-Jing Zhao, Lu Xu, Cai-Long Pan, Zhi-Yuan Zhang
Published 2020-02-01

PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies

by Silva-Abreu M, Calpena AC, Andrés-Benito P, Aso E, Romero IA, Roig-Carles D, Gromnicova R, Espina M, Ferrer I, García ML, Male D
Published 2018-09-01

Quetiapine modulates anxiety-like behaviours and alleviates the decrease of BDNF in the amygdala of an APP/PS1 transgenic mouse model of Alzheimers disease

by Tempier, Adrien Paul
Published 2009

Acute Down-regulation of BDNF Signaling Does Not Replicate Exacerbated Amyloid-β Levels and Cognitive Impairment Induced by Cholinergic Basal Forebrain Lesion

by Marion T. Turnbull, Zoran Boskovic, Elizabeth J. Coulson, Elizabeth J. Coulson
Published 2018-02-01

BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer′s disease

by Lan Li, Jia Luo, Dan Chen, Jian-bin Tong, Le-ping Zeng, Yan-qun Cao, Jian Xiang, Xue-gang Luo, Jing-ming Shi, Hui Wang, Ju-fang Huang
Published 2016-01-01